Plain-English translation of NCT06771323 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a medication that works on dopamine pathways in the brain, can help reduce cervical dystonia symptoms when used together with your regular botulinum toxin injections. The study will compare to a placebo (a dummy pill) to see if the medication is safe and effective as an add-on treatment. If the medication works, it could offer people with neck dystonia another tool to manage their symptoms.
Botulinum toxin injections help many people with cervical dystonia, but some patients still have significant symptoms or don't respond well enough. This medication has shown promise in treating related movement disorders, and early evidence suggests it might help when combined with botulinum toxin, but this hasn't been properly tested yet.
You likely qualify if…
You likely don't qualify if…
You will participate in the study for 6 months total. Half of participants will receive a placebo pill for the first 3 months (during one cycle of botulinum toxin injections), then switch to for the next 3 months. The other half will do the opposite— first, then placebo. You'll continue getting your regular botulinum toxin injections every 3 months as usual, and take the study medication or placebo by mouth during this time. The study team will monitor your symptoms and any side effects throughout.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States